CION Cancer Clinics
Reading the endoscopic resection specimen report | CION Cancer Clinics
The pathology report after an EMR or ESD answers three questions: what the growth was, how deep it went, and whether the edges, called margins, were clear. Those three answers decide whether the resection was enough on its own or whether an operation should follow. This page explains each word on the report, the four patterns most reports fall into, and what the report cannot tell you. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
On this page
- What is the specimen report actually telling me?
- The words on the report, in plain language
- What do the results usually add up to?
- What the report says, and what it usually means for the next step
- Four things families read into the report, and what is true
- What the report cannot tell you
- Common questions about the endoscopic resection report
The short answer
What is the specimen report actually telling me?
The report answers three questions about the piece removed at your EMR or ESD: what it was, how deep it went, and whether the edges were clear. Those three answers, read together, decide whether the resection was enough on its own or whether an operation should follow. Nothing else on the page matters as much.
Why the edges get their own line
The pathologist inks the outside of the specimen, then cuts it into thin slices and looks at whether abnormal cells reach the inked edge. There are two edges that matter. The lateral margin is the rim around the sides. The deep margin, sometimes called the vertical margin, is the underside, where the growth was lifted off the muscle. A clear deep margin is the more important of the two.
Why a piecemeal specimen reads differently
If the growth came out in several pieces, the pathologist cannot always line the edges up. The report may say the margin cannot be assessed. That is not a bad result in itself. It means the check scope at the site carries more weight, because the microscope could not settle the question.
Who should read it with you
The endoscopist who did the procedure, or a surgical oncologist. A pathology report is written for another doctor, and a single word out of context can frighten a family for a week.
If the report says "adenoma" or "dysplasia" and nothing about invasion, it is describing a growth that was not yet a cancer.On your report
The words on the report, in plain language
- En bloc
- Removed in one piece. The pathologist can judge every edge, which is why ESD aims for it.
- Piecemeal
- Removed in fragments. The growth may still be fully gone, but the edges cannot always be confirmed under the microscope.
- R0, R1, Rx
- R0 means no abnormal cells at any edge. R1 means abnormal cells reach an edge. Rx means the edges could not be assessed, usually because of piecemeal removal or heat damage.
- High-grade dysplasia or intramucosal carcinoma
- Abnormal cells confined to the lining itself, without reaching the layer beneath. In the bowel, this is generally treated as fully dealt with once removed, and is not staged as an invasive cancer.
- Submucosal invasion
- Cancer has grown through the lining into the layer beneath. The report gives a depth, in micrometres or as a fraction of the layer. Your team compares it against a guideline threshold.
- Lymphovascular invasion
- Cancer cells seen inside tiny blood or lymph vessels. It raises the chance that cells have reached a lymph gland.
- Tumour budding
- Small clusters of cells breaking away from the main edge of the cancer. Reported as low, intermediate or high. Higher counts weigh towards an operation.
- Differentiation or grade
- How much the cells still resemble normal lining. Well and moderately differentiated are lower risk. Poorly differentiated is higher.
Not sure whether this applies to you?
Ask an oncologistThe four patterns
What do the results usually add up to?
Most reports fall into one of these four groups. Your team will tell you which is yours, and why.
Not a cancer
Adenoma, dysplasia of any grade, or intramucosal change only, with clear edges. The resection has dealt with it. The next step is a check scope to make sure nothing regrows at the site.
Early cancer, all low-risk features
Cancer that entered the layer beneath the lining only shallowly, with no vessel invasion, no high-grade cells, no budding and clear edges. Many teams consider the resection sufficient, with close follow-up. A tumour board usually confirms this.
Early cancer with a high-risk feature
Deep invasion, vessel invasion, poor differentiation, high budding, or cancer at the deep edge. Any one of these raises the chance of lymph gland involvement, and an operation is usually discussed.
What that discussion covers
- Which feature triggered it
- Your fitness for an operation
- What watching instead would involve
Cannot be assessed
Piecemeal fragments, heat damage at the edges, or a specimen too small to orient. The pathologist cannot say whether the edges are clear. The team then relies on the check scope, a second review of the slides, or both.
Side by side
What the report says, and what it usually means for the next step
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Four things families read into the report, and what is true
A growth that looked early was removed through the scope precisely so that a pathologist could examine it whole. If the word carcinoma appears with shallow depth and clear edges, the scope may have been the whole treatment. If not, the specimen has shown exactly why an operation is needed.
It means abnormal cells reached the inked edge of the piece. Whether any remain in you is a different question. Heat used to seal the wound often destroys a rim of tissue, which is why a positive lateral margin is usually followed by a check scope rather than an operation.
It is the step before cancer, still confined to the lining. Once removed with clear edges it is generally considered fully treated. The word high-grade frightens people, and it should be explained rather than left to worry about.
Depth, budding and vessel invasion are judgements made by a person at a microscope. When a decision about an operation rests on one of them, asking for a second pathologist to review the slides is normal, and good teams welcome it.
Being straight with you
What the report cannot tell you
The report describes the piece that was removed. It cannot see the lymph glands, which were not removed, and it cannot see the rest of the body. Whether cancer has reached a gland is estimated from the report features, and confirmed only by an operation or by time.
It does not give a prognosis
Nothing on the report says how things will go for you. Prognosis, meaning the likely course, depends on the full stage, your health and how the next steps unfold. Anyone who reads a future off a specimen report alone is guessing.
It may be revised
Extra stains, a second pathologist, or a deeper cut through the block can change a line on the report. If your team says they are waiting for further stains or a review, that is care being taken, not something being hidden. Ask when the final version is expected.
What to bring to the appointment
The full report, including any addendum, the endoscopy report with photographs, and a written list of questions. Ask which pattern above your report fits, and which lines drove the recommendation.
Send us the report and we will go through it with you. A CION surgical oncologist reads it, not a call handler.Questions we are asked
Common questions about the endoscopic resection report
How long does the report take?
Usually several working days for the main report. Extra stains to look for vessel invasion or to confirm the type of cells can add a few more days. If your team says the report is provisional, the final version may change a line. Ask when it is expected rather than reading the draft alone.
The report says "margins not assessable". Is that bad?
Not in itself. It usually means the growth came out in pieces, or heat damaged the edges, so the pathologist could not line them up. The check scope at the site becomes the main way of confirming nothing was left. Your endoscopist will usually bring that scope forward.
What does "invasive" mean on my report?
That cancer cells have grown through the lining into the layer beneath. It is the point at which a growth is called a cancer rather than a pre-cancer. How deep it went, and whether other features are present, decide whether the resection was enough. Invasive does not mean spread.
Can the slides be sent to another pathologist?
Yes. Ask the hospital for the slides or the paraffin blocks, which are yours to request. A second review is sensible when an operation is being recommended on the strength of one feature such as budding or depth. Most centres in Hyderabad can arrange this within a week or two.
Why does the report mention the stomach and the bowel differently?
The thresholds for depth and the features that matter differ by organ. A depth that is low risk in the bowel may be treated differently in the food pipe, and stomach reports use their own criteria. Your team applies the guideline for the organ involved, which is why comparing reports between relatives misleads.
If the edges are clear, am I finished with treatment?
Clear edges are the first requirement, not the only one. If the growth was not a cancer, or was a cancer with all low-risk features, clear edges usually mean the resection was the treatment, followed by check scopes. If a high-risk feature is present, clear edges do not settle it on their own.
Should I get the report translated into Telugu?
A word-for-word translation rarely helps, because the difficulty is the meaning, not the language. What helps is a doctor explaining each line in Telugu or plain English. Ask for that at the appointment, and bring a family member who can take notes while you listen.
Does the report affect my insurance or Aarogyasri approval?
It is usually the document that unlocks the next approval. Aarogyasri, CGHS, ECHS, EHS and cashless insurers all ask for the pathology report when an operation is proposed. Keep the original and several copies. Call the helpline if you are unsure what the scheme needs from you.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer Research UK — Bowel cancer
- National Cancer Institute — Pathology reports
- American Cancer Society — Understanding your pathology report
- NICE — Colorectal cancer (NG151)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Holding a report you do not understand?
Send it to us. A CION surgical oncologist will go through it line by line with you and tell you what the next step actually is.